Royal London Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240M | Sell |
|
|||||
|
2025
Q1 | $367M | Sell |
|
|||||
|
2024
Q4 | $395M | Sell |
|
|||||
|
2024
Q3 | $477M | Sell |
|
|||||
|
2024
Q2 | $457M | Sell |
|
|||||
|
2024
Q1 | $509M | Buy |
|
|||||
|
2023
Q4 | $461M | Buy |
|
|||||
|
2023
Q3 | $435M | Buy |
|
|||||
|
2023
Q2 | $437M | Buy |
|
|||||
|
2023
Q1 | $455M | Buy |
|
|||||
|
2022
Q4 | $427M | Buy |
|
|||||
|
2022
Q3 | $391M | Buy |
|
|||||
|
2022
Q2 | $413M | Buy |
|
|||||
|
2022
Q1 | $445M | Buy |
|
|||||
|
2021
Q4 | $499M | Sell |
|
|||||
|
2021
Q3 | $431M | Buy |
|
|||||
|
2021
Q2 | $379M | Buy |
|
|||||
|
2021
Q1 | $255M | Buy |
|
|||||
|
2020
Q4 | $233M | Sell |
|
|||||
|
2020
Q3 | $221M | Buy |
|
|||||
|
2020
Q2 | $145M | Buy |
|
|||||
|
2020
Q1 | $114M | Buy |
|
|||||
|
2019
Q4 | $88.8M | Buy |
|
|||||
|
2019
Q3 | $75.9M | Sell |
|
|||||
|
2019
Q2 | $77.1M | Buy |
|
|||||
|
2019
Q1 | $70.3M | Buy |
|
|||||
|
2018
Q4 | $54.1M | Buy |
|
|||||
|
2018
Q3 | $43.1M | Buy |
|
|||||
|
2018
Q2 | $35.9M | Buy |
|
|||||
|
2016
Q2 | $19.9M | Sell |
|
|||||
|
2016
Q1 | $97K | Buy |
|
|||||
|
2015
Q4 | $20.4M | Buy |
|
|||||
|
2015
Q3 | $17.3M | Buy |
|
|||||
|
2014
Q4 | $159K | Buy |
|
|||||
|
2014
Q3 | $11.9M | Buy |
|
|||||
|
2014
Q2 | $11.1M | Sell |
|
|||||
|
2014
Q1 | $11M | Buy |
|
|||||
|
2013
Q4 | $9.7M | Buy |
|
|||||
|
2013
Q3 | $8.13M | Buy |
|
|||||
|
2013
Q2 | $7.09M | Buy |
|